209 related articles for article (PubMed ID: 36399643)
21. Enhanced Anti-Tumor Activity in Mice with Temozolomide-Resistant Human Glioblastoma Cell Line-Derived Xenograft Using SN-38-Incorporated Polymeric Microparticle.
Yang TC; Liu SJ; Lo WL; Chen SM; Tang YL; Tseng YY
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34074038
[TBL] [Abstract][Full Text] [Related]
22. Cordycepin Augments the Chemosensitivity of Human Glioma Cells to Temozolomide by Activating AMPK and Inhibiting the AKT Signaling Pathway.
Bi Y; Li H; Yi D; Sun Y; Bai Y; Zhong S; Song Y; Zhao G; Chen Y
Mol Pharm; 2018 Nov; 15(11):4912-4925. PubMed ID: 30336060
[TBL] [Abstract][Full Text] [Related]
23. Targeted nanocomplex carrying siRNA against MALAT1 sensitizes glioblastoma to temozolomide.
Kim SS; Harford JB; Moghe M; Rait A; Pirollo KF; Chang EH
Nucleic Acids Res; 2018 Feb; 46(3):1424-1440. PubMed ID: 29202181
[TBL] [Abstract][Full Text] [Related]
24. miR-519a enhances chemosensitivity and promotes autophagy in glioblastoma by targeting STAT3/Bcl2 signaling pathway.
Li H; Chen L; Li JJ; Zhou Q; Huang A; Liu WW; Wang K; Gao L; Qi ST; Lu YT
J Hematol Oncol; 2018 May; 11(1):70. PubMed ID: 29843746
[TBL] [Abstract][Full Text] [Related]
25. Novel Targeting of Transcription and Metabolism in Glioblastoma.
Su YT; Chen R; Wang H; Song H; Zhang Q; Chen LY; Lappin H; Vasconcelos G; Lita A; Maric D; Li A; Celiku O; Zhang W; Meetze K; Estok T; Larion M; Abu-Asab M; Zhuang Z; Yang C; Gilbert MR; Wu J
Clin Cancer Res; 2018 Mar; 24(5):1124-1137. PubMed ID: 29254993
[No Abstract] [Full Text] [Related]
26. Tailoring drug co-delivery nanosystem for mitigating U-87 stem cells drug resistance.
Behrooz AB; Vazifehmand R; Tajudin AA; Masarudin MJ; Sekawi Z; Masomian M; Syahir A
Drug Deliv Transl Res; 2022 May; 12(5):1253-1269. PubMed ID: 34405338
[TBL] [Abstract][Full Text] [Related]
27. IRGD-modified erythrocyte membrane biomimetic temozolomide nanodots for the treatment of glioblastoma.
Luo D; Chen Z; Peng Y; Liu C
Nanotechnology; 2024 Mar; 35(24):. PubMed ID: 38408368
[TBL] [Abstract][Full Text] [Related]
28. miR-126-3p sensitizes glioblastoma cells to temozolomide by inactivating Wnt/β-catenin signaling via targeting SOX2.
Luo W; Yan D; Song Z; Zhu X; Liu X; Li X; Zhao S
Life Sci; 2019 Jun; 226():98-106. PubMed ID: 30980849
[TBL] [Abstract][Full Text] [Related]
29. Long noncoding RNA just proximal to X-inactive specific transcript facilitates aerobic glycolysis and temozolomide chemoresistance by promoting stability of PDK1 mRNA in an m6A-dependent manner in glioblastoma multiforme cells.
Li XD; Wang MJ; Zheng JL; Wu YH; Wang X; Jiang XB
Cancer Sci; 2021 Nov; 112(11):4543-4552. PubMed ID: 34390075
[TBL] [Abstract][Full Text] [Related]
30. Modulating lncRNA SNHG15/CDK6/miR-627 circuit by palbociclib, overcomes temozolomide resistance and reduces M2-polarization of glioma associated microglia in glioblastoma multiforme.
Li Z; Zhang J; Zheng H; Li C; Xiong J; Wang W; Bao H; Jin H; Liang P
J Exp Clin Cancer Res; 2019 Aug; 38(1):380. PubMed ID: 31462285
[TBL] [Abstract][Full Text] [Related]
31. Silencing of ZFP36L2 increases sensitivity to temozolomide through G2/M cell cycle arrest and BAX mediated apoptosis in GBM cells.
Che Mat MF; Mohamad Hanif EA; Abdul Murad NA; Ibrahim K; Harun R; Jamal R
Mol Biol Rep; 2021 Feb; 48(2):1493-1503. PubMed ID: 33590411
[TBL] [Abstract][Full Text] [Related]
32. Euphol, a tetracyclic triterpene, from Euphorbia tirucalli induces autophagy and sensitizes temozolomide cytotoxicity on glioblastoma cells.
Silva VAO; Rosa MN; Miranda-Gonçalves V; Costa AM; Tansini A; Evangelista AF; Martinho O; Carloni AC; Jones C; Lima JP; Pianowski LF; Reis RM
Invest New Drugs; 2019 Apr; 37(2):223-237. PubMed ID: 29931585
[TBL] [Abstract][Full Text] [Related]
33. ProNGF Expression and Targeting in Glioblastoma Multiforme.
Marsland M; Dowdell A; Faulkner S; Jobling P; Rush RA; Gedye C; Lynam J; Griffin CP; Baker M; Marsland J; Jiang CC; Hondermarck H
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675126
[TBL] [Abstract][Full Text] [Related]
34. Leucine-rich repeat containing 4 act as an autophagy inhibitor that restores sensitivity of glioblastoma to temozolomide.
Feng J; Zhang Y; Ren X; Li D; Fu H; Liu C; Zhou W; Liu Q; Liu Q; Wu M
Oncogene; 2020 Jun; 39(23):4551-4566. PubMed ID: 32372061
[TBL] [Abstract][Full Text] [Related]
35. Study on Therapeutic Action and Mechanism of TMZ Combined with RITA Against Glioblastoma.
Wu Q; Cao Z; Xiao W; Zhu L; Xie Q; Li L; Zhang B; Zhao W
Cell Physiol Biochem; 2018; 51(6):2536-2546. PubMed ID: 30562758
[TBL] [Abstract][Full Text] [Related]
36. Biomimetic Dp44mT-nanoparticles selectively induce apoptosis in Cu-loaded glioblastoma resulting in potent growth inhibition.
Ismail M; Yang W; Li Y; Wang Y; He W; Wang J; Muhammad P; Chaston TB; Rehman FU; Zheng M; Lovejoy DB; Shi B
Biomaterials; 2022 Oct; 289():121760. PubMed ID: 36044788
[TBL] [Abstract][Full Text] [Related]
37. Hsa_circ_0072309 enhances autophagy and TMZ sensitivity in glioblastoma.
Yuan F; Zhang S; Sun Q; Ye L; Xu Y; Xu Z; Deng G; Zhang S; Liu B; Chen Q
CNS Neurosci Ther; 2022 Jun; 28(6):897-912. PubMed ID: 35212145
[TBL] [Abstract][Full Text] [Related]
38. BET inhibitor I-BET151 sensitizes GBM cells to temozolomide via PUMA induction.
Yao Z; Yang S; Zhao H; Yang H; Jiang X
Cancer Gene Ther; 2020 Apr; 27(3-4):226-234. PubMed ID: 30518782
[TBL] [Abstract][Full Text] [Related]
39. A multicenter phase II study of temozolomide plus disulfiram and copper for recurrent temozolomide-resistant glioblastoma.
Huang J; Chaudhary R; Cohen AL; Fink K; Goldlust S; Boockvar J; Chinnaiyan P; Wan L; Marcus S; Campian JL
J Neurooncol; 2019 May; 142(3):537-544. PubMed ID: 30771200
[TBL] [Abstract][Full Text] [Related]
40. Rutin increases the cytotoxicity of temozolomide in glioblastoma via autophagy inhibition.
Zhang P; Sun S; Li N; Ho ASW; Kiang KMY; Zhang X; Cheng YS; Poon MW; Lee D; Pu JKS; Leung GKK
J Neurooncol; 2017 May; 132(3):393-400. PubMed ID: 28293765
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
